» Articles » PMID: 29488821

Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection

Overview
Journal Physiol Rev
Specialty Physiology
Date 2018 Mar 1
PMID 29488821
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

It has long been thought that respiratory infections are the direct result of acquisition of pathogenic viruses or bacteria, followed by their overgrowth, dissemination, and in some instances tissue invasion. In the last decades, it has become apparent that in contrast to this classical view, the majority of microorganisms associated with respiratory infections and inflammation are actually common members of the respiratory ecosystem and only in rare circumstances do they cause disease. This suggests that a complex interplay between host, environment, and properties of colonizing microorganisms together determines disease development and its severity. To understand the pathophysiological processes that underlie respiratory infectious diseases, it is therefore necessary to understand the host-bacterial interactions occurring at mucosal surfaces, along with the microbes inhabiting them, during symbiosis. Current knowledge regarding host-bacterial interactions during asymptomatic colonization will be discussed, including a plausible role for the human microbiome in maintaining a healthy state. With this as a starting point, we will discuss possible disruptive factors contributing to dysbiosis, which is likely to be a key trigger for pathobionts in the development and pathophysiology of respiratory diseases. Finally, from this renewed perspective, we will reflect on current and potential new approaches for treatment in the future.

Citing Articles

Evaluating the Risks of Heated Tobacco Products: Toxicological Effects on Two Selected Respiratory Bacteria and Human Lung Cells.

Furnari S, Emma R, Caruso M, Furneri P, Fuochi V Toxics. 2025; 13(2).

PMID: 39997888 PMC: 11860425. DOI: 10.3390/toxics13020070.


The Derivative Difluoroboranyl-Fluoroquinolone "7a" Generates Effective Inhibition Against the Strain in a Murine Model of Acute Pneumonia.

Veyna-Hurtado L, Hernandez-Lopez H, Reyes-Escobedo F, de Loera D, Garcia-Cruz S, Troncoso-Vazquez L Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996831 PMC: 11854692. DOI: 10.3390/cimb47020110.


Corynebacteria from the respiratory microbiota modulate inflammatory responses and associate with a reduced pneumococcal burden in the lungs.

Bergenfelz C, Do P, Larsson L, Ivarsson H, Malmborn K, Hakansson A Front Cell Infect Microbiol. 2025; 14:1530178.

PMID: 39935537 PMC: 11811110. DOI: 10.3389/fcimb.2024.1530178.


Effects of vaccination and interventions on nasal microbiome and BRD-associated pathogens in calves.

Liu G, Zhang S, Xiang Z, Shirani I, Chen Y, Guo A Front Microbiol. 2024; 15:1467908.

PMID: 39624725 PMC: 11610248. DOI: 10.3389/fmicb.2024.1467908.


Predicting potential microbe-disease associations based on dual branch graph convolutional network.

Chen J, Zhu Y, Yuan Q J Cell Mol Med. 2024; 28(15):e18571.

PMID: 39086148 PMC: 11291560. DOI: 10.1111/jcmm.18571.


References
1.
Voyno-Yasenetskaya T, Dobbs L, Williams M . Regulation of ATP-dependent surfactant secretion and activation of second-messenger systems in alveolar type II cells. Am J Physiol. 1991; 261(4 Suppl):105-9. DOI: 10.1152/ajpheart.1991.261.4.105. View

2.
Lo J, Kulp S, Chen C, Chiu H . Sensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agent. Antimicrob Agents Chemother. 2014; 58(12):7375-82. PMC: 4249550. DOI: 10.1128/AAC.03778-14. View

3.
Karav S, Le Parc A, de Moura Bell J, Frese S, Kirmiz N, Block D . Oligosaccharides Released from Milk Glycoproteins Are Selective Growth Substrates for Infant-Associated Bifidobacteria. Appl Environ Microbiol. 2016; 82(12):3622-3630. PMC: 4959171. DOI: 10.1128/AEM.00547-16. View

4.
Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss D, Leiberman A . Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J. 1998; 17(10):880-5. DOI: 10.1097/00006454-199810000-00006. View

5.
Drago L, De Vecchi E, Torretta S, Mattina R, Marchisio P, Pignataro L . Biofilm formation by bacteria isolated from upper respiratory tract before and after adenotonsillectomy. APMIS. 2012; 120(5):410-6. DOI: 10.1111/j.1600-0463.2011.02846.x. View